Fabry Disease

Häftad, Engelska, 2014

AvDeborah Elstein,Gheona Altarescu,Michael Beck

2 359 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Fabry disease is an X-linked inborn error of metabolism wherein deficiency of a lysosomal enzyme results in systemic deposition of glycosphingolipids.

Produktinformation

Utgivningsdatum2014-09-29
Mått155 x 235 x 30 mm
Vikt826 g
FormatHäftad
SpråkEngelska
Antal sidor512
FörlagSpringer
ISBN9789400798847

Tillhör följande kategorier

Medicinsk genetik inom Medicin
Sjukdomar och rubbningar inom Medicin

Pre-Clinical.- Molecular Genetics of Fabry Disease and Genotype–Phenotype Correlation.- The Structure of Human ?-Galactosidase A and Implications for Fabry Disease.- Subcellular, Cellular and Organ Pathology of Fabry Disease.- Biochemistry of Fabry Disease.- Clinically Relevant Examples of Genotype–Phenotype Correlation.- Laboratory Diagnosis of Fabry Disease.- Biomarkers for Fabry Disease.- Fabry Disease Case Finding Studies in High-Risk Populations.- Small Molecule Drug Discovery for Fabry Disease.- Clinical.- Clinical Manifestations of Fabry Disease: An Overview.- The Heart in Fabry Disease – from Pathogenesis to Enzyme Replacement Therapy.- Renal Manifestations of Fabry Disease.- Neurological Manifestations in Fabry Disease.- Dermatological Manifestations of Fabry Disease.- Histopathology of Skin in Fabry Disease.- Bone and Muscle Involvement in Fabry Disease.- The Eye in Fabry Disease.- Pulmonary, Ear and Less Commonly Appreciated Manifestations.- Neuropsychiatric Manifestations of AFD.- Genetic Counseling and Psychosocial Issues for Individuals and Their Families with Fabry Disease.- Fabry Disease in Females.- Fabry Disease in Pediatric Patients.- Experimental Studies in Mice on the Vasculopathy of Fabry Disease.- Management.- Overview.- Agalsidase Alfa in the Treatment of Anderson-Fabry Disease.- Agalsidase Beta Clinical Trials and Long Term Experience.- Analyses of Agalsidase Alfa and Agalsidase Beta for the Treatment of Fabry Disease.- Enzyme Replacement Therapy in Children with Fabry Disease.- Pharmacological Chaperone Therapy for Fabry Disease.- Potential Factors Influencing Treatment Outcomes.- Symptomatic and Ancillary Therapy.- The Price of Care Versus the Cost of Caring.

From the reviews: "As the first book dedicated to Fabry Disease, this provides an extensive, detailed review of all current information about this rare disorder. ... The information presented here will serve genetics specialists in the evaluation, surveillance, and management of affected patients with this rare disorder. ... It is also a well-written and informative tool for families affected by this disorder, helping them understand its natural course and available treatment. ... This highly specialized, unique book on this rare disorder has no comparison." (Luis F. Escobar, Doody's Review Service, March, 2012)